Atlas Trials

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

Clinical trial NCT04432883 · RECRUITING

Trial details

NCT number
NCT04432883
Sponsor
University of New Mexico
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
StrokeAphasia
Start date
2022-10-18
Primary completion
2027-03-26
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.